Page last updated: 2024-09-04

cyc 202 and Cholera Infantum

cyc 202 has been researched along with Cholera Infantum in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Filipski, E; Guettier, C; Harper, F; Hassan, M; Iacobelli, S; Iurisci, I; Lévi, F; Maire, I; Sallam, H	1

Other Studies

1 other study(ies) available for cyc 202 and Cholera Infantum

Article	Year
Liver circadian clock, a pharmacologic target of cyclin-dependent kinase inhibitor seliciclib. Chronobiology international, 2009, Volume: 26, Issue:6 Topics: Animals; Antineoplastic Agents; Area Under Curve; Biological Clocks; Cell Cycle; Chemical and Drug Induced Liver Injury; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Gastrointestinal Diseases; Gene Expression Regulation; Liver; Male; Mice; Purines; Roscovitine	2009

Article

Year

Liver circadian clock, a pharmacologic target of cyclin-dependent kinase inhibitor seliciclib.

Chronobiology international, 2009, Volume: 26, Issue:6

Topics: Animals; Antineoplastic Agents; Area Under Curve; Biological Clocks; Cell Cycle; Chemical and Drug Induced Liver Injury; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Gastrointestinal Diseases; Gene Expression Regulation; Liver; Male; Mice; Purines; Roscovitine

2009